跳至主要内容
临床试验/NL-OMON23091
NL-OMON23091已完成不适用

A phase II randomized multicenter study on efficacy and safety of cultured autologous skin (Tiscover®) and acellular dermal matrix (AS210) in chronic (arterio-)venous ulcers.

Free University medical center (VUmc)0 个研究点目标入组 49 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
49

研究概览

简要总结

Wound healing in venous ulcers; mechanisms, approach and modern developments. Gibbs S, van den Hoogenband HM, de Boer EM. Ned Tijdschr Geneeskd. 2007 Mar 17;151(11):635-40. Review. Dutch. Autologous full-thickness skin substitute for healing chronic wounds.Gibbs S, van den Hoogenband HM, Kirtschig G, Richters CD, Spiekstra SW, Breetveld M, Scheper RJ, de Boer EM. Br J Dermatol. 2006 Aug;155(2):267-74.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Presence of confirmed venous, arterio-venous ulcer;
  • 2. Patients age over 18 years and under age of 90 years;

排除标准

  • 1. Ulcer chronicity < 12 weeks;
  • 2. >15% increase of ulcer size in 4 weeks prior to inclusion or confirmed by historical data (patient status);

研究者

发起方
Free University medical center (VUmc)

相似试验

Autologous Skin Substitute for leg ulcers. | 临床试验